Ketamine infusions can ease PTSD for some people, and the evidence for that comes from small trials. In the clearest of them, 30 adults with long-standing PTSD had six infusions over two weeks, and 67% responded on ketamine against 20% on the comparison drug (Feder and colleagues, American Journal of Psychiatry, 2021). Depression trials run more than ten times that size, and the biggest PTSD trial so far, in veterans, found no advantage over placebo. The part you can shape is what surrounds the infusions: an assessment that takes your trauma history into account, your own therapist for the trauma work through the three weeks, and sessions with a psychotherapist here once the six infusions are done.
What studies of ketamine for PTSD show
The three main trials compared ketamine with placebo or with midazolam, a sedative people can feel, so it is harder to guess which drug they had.
| Trial | Who took part | Infusions | What happened to PTSD symptoms |
|---|---|---|---|
| Feder and colleagues, 2014, JAMA Psychiatry | 41 adults, varied trauma | one, crossed over with midazolam | 12.7 points lower on a symptom scale at 24 hours |
| Feder and colleagues, 2021, American Journal of Psychiatry | 30 adults | six over two weeks, against midazolam | 67% responded, against 20% on midazolam |
| Abdallah and colleagues, 2022, Neuropsychopharmacology | 158 veterans and service members | eight over four weeks, two doses, against placebo | no difference from placebo |
Pooling ten studies, only five of them randomised, a 2024 meta-analysis found improvement that reached significance only at the end of a course, with a small effect and wide variation between studies (Almeida and colleagues, Clinical Neuropsychiatry, 2024).
The gap between civilian and veteran results is why a psychiatrist with your history decides whether infusions suit you, not an average from a table.
How PTSD trials differ from depression trials, and what follows from it
A 2026 systematic review found seven randomised trials of intravenous ketamine for PTSD, with 323 participants between them, and in two of them symptoms improved meaningfully more than on the control (Yin and colleagues, Acta Psychiatrica Scandinavica). One depression trial alone randomised 403 people (Anand and colleagues, New England Journal of Medicine, 2023). In trials this small, a handful of strong responders can swing the result.
Many people in PTSD trials have depression as well, and the two can move separately, as the veterans’ trial below shows. If your trauma goes back years and the diagnosis is complex PTSD, what these trials can and cannot tell you about complex PTSD is set out on its own page.
How does ketamine work for PTSD: what happens to the memory of the trauma
Ketamine acts on the glutamate system, which the brain uses for learning and for the extinction and reconsolidation of memories. One idea behind its use in PTSD is about timing: when a memory is recalled it enters a labile state, and in that window it can be stored again in an altered form (Duek and colleagues, Neuropsychopharmacology, 2023).
A pilot trial tested this in 27 people with PTSD. They recalled the traumatic memory, then had an infusion of ketamine or of midazolam, and the next day began four days of trauma-focused therapy (Duek and colleagues, 2023). PTSD symptoms improved by the same amount in both groups. What differed was the brain. In the ketamine group, the amygdala, a region that reacts to threat, reacted less to a recording of the person’s own trauma story at the end of treatment. The authors read this as a possible sign that ketamine strengthens the relearning that follows recall of the memory, and they call the finding preliminary.
Animal research is less tidy. A 2025 review found that ketamine helped, hindered or made no difference to this kind of relearning, depending on the dose, the route and when it was given (Boese and colleagues, Frontiers in Neuroscience).
For you, this means the memory is not erased. In that trial the work on the memory was done in four days of trauma-focused therapy after the infusion, and the symptom change came out the same in both groups. In ketamine therapy forums, people describe sessions very differently: for some, old feelings about the trauma come back, and others notice little at all. If you have a therapist, a question worth putting to them is where their sessions should sit around your infusion dates: in the one trial that paired the two, the therapy started the day after the infusion (Duek and colleagues, 2023).
How a course of infusions is set up, and what happens between sessions
Our course is six infusions into a vein over three weeks, two a week, at our partner clinic in Malta. Each infusion takes about 40 minutes. Dr Christopher Gauci, an anaesthetist, gives every one and watches your heart rate and blood pressure the whole time. You rest until you feel steady, usually within a couple of hours, and you do not drive until the next day, so someone goes back with you.
Two a week for three weeks is the schedule of the largest infusion trial so far, the 403-person depression trial above. The six-infusion PTSD trial gave three a week over two weeks (Feder and colleagues, 2021), and the 2026 review compared single doses against repeated ones rather than one repeated schedule against another (Yin and colleagues). So the doctor checks your response at each infusion, and if nothing is moving, says so and talks through what that means for the rest of the course.
Between infusions you are not in the clinic, and trauma does not keep to the appointment diary. Some people book a course around a hard date, such as the anniversary of what happened. Others find memories surfacing on an ordinary afternoon two days after an infusion.
Three things make those days easier to use:
- Write down what comes up, with the day and what set it off. A few lines are enough.
- Keep your usual supports in place. A therapist, a partner or a friend who knows what the course is for, and who you can call that evening.
- Bring it to the next infusion. The doctor sees you at every one, so that is where to say how the days in between went.
If you get markedly worse between infusions, do not wait for the next one. Tell our team the same day, and go to your own doctor or to emergency services if you do not feel safe.
Why trauma-focused therapy belongs around the infusions
The main treatments for PTSD are talk therapy, medicines, or both, and which of them fits is worked out with a clinician (MedlinePlus, US National Library of Medicine). Ketamine for PTSD is given off-label, and the 2026 review of seven intravenous trials asks for studies of it combined with psychotherapy (Yin and colleagues).
The trials that gave infusions on their own measured the benefit in weeks. In the six-infusion trial, people who responded kept the change for a median of 27.5 days after the last infusion (Feder and colleagues, 2021). Those are the weeks that the plan after the course covers.
Pairing ketamine with therapy has been studied less cleanly. A 2026 analysis of individual results from 12 studies with 533 participants found that people who had more therapy sessions alongside ketamine tended to improve more, but nine of the studies were of poor quality (Rohde and colleagues, Psychotherapy and Psychosomatics). Restricted to the stronger studies, only how severe symptoms were at the start predicted the result, and the authors ask for caution. The memory trial in the section above points the same way: with therapy in place, both groups improved.
In practice that means planning the trauma work to run past the last infusion. On our course, sessions with a psychotherapist are available once the six are done. If you already see a therapist for PTSD, you can keep working with them through the course and after it; we do the assessment and the infusions. Before you book dates, ask your therapist how they would place sessions around the course and in the weeks after the last infusion: that is their judgement with you, not ours.
What the largest trial in veterans and service members showed, and what it means for civilian PTSD with therapy alongside
The largest ketamine trial in PTSD ran at several sites in the United States. It enrolled 158 veterans and active-duty service members whose PTSD had not responded to antidepressants. They had eight infusions, twice a week, of placebo, a low dose or the standard dose, and were followed for four weeks after (Abdallah and colleagues, 2022).
On PTSD, neither dose did better than placebo, on the self-rated scale or the clinician’s. On depression, the standard dose did: scores fell more than on placebo, and quickly. People on ketamine were no more likely to drop out.
What it does not show is that ketamine fails in PTSD across the board. The civilian trials enrolled people after many kinds of trauma and found symptoms falling within days (Feder and colleagues, 2014 and 2021). The veterans here had long-standing symptoms that antidepressants had not eased. And none of the three groups was defined by therapy, so the trial says nothing about infusions with trauma-focused work alongside.
What it does suggest is narrower: the trial failed to find a dose-related effect of ketamine on PTSD symptoms, and its secondary analyses pointed to a rapid fall in depression scores at the standard dose (Abdallah and colleagues, 2022). If you served, write down which treatments you had through military or veterans’ services and which symptoms each one changed, and bring that to a first call with our team.
What the PTSD trials recorded on safety
- Within 2 hours. Dissociation from each infusion returned to where it started, and it weakened as infusions were repeated, in 158 veterans (Abdallah and colleagues, 2022)
- No serious adverse events. Over six infusions in two weeks in the 30-person trial (Feder and colleagues, 2021)
- Rising with the dose. Dissociation and other changes in perception were stronger at the standard dose than at the low one (Abdallah and colleagues, 2022)
Is ketamine therapy dangerous: side effects and the risk of getting worse with trauma
In the three controlled trials, PTSD symptoms on ketamine ended lower than on the comparison drug or about the same, over the weeks they were followed (Feder and colleagues, 2014 and 2021; Abdallah and colleagues, 2022). Who is more exposed and what to do about a hard stretch are covered on the page about whether ketamine can make PTSD worse.
The effects people do feel are listed on the label. Ketamine’s most common reactions there are emergence reactions, the altered perception and mood changes as the drug wears off, and raised blood pressure and pulse; nausea, vomiting and double vision are listed too (FDA label for Ketalar). A 2018 review of 60 studies of ketamine for depression, not PTSD, found psychiatric, heart and blood pressure, and neurological effects reported more often after ketamine than after placebo (Short and colleagues, Lancet Psychiatry). In the first PTSD trial, ketamine was generally well tolerated, with no dissociation that lasted beyond the session (Feder and colleagues, 2014).
The serious harms of ketamine, bladder damage and dependence, are linked mainly to frequent, heavy recreational use (Morgan and Curran, Addiction, 2012). On our course a doctor gives every infusion, there are no doses to take home, and the course is fixed at six.
Before the first infusion, tell someone close to you your dates, so they know what the course involves and can be around in the days after.
What is checked before an infusion for trauma, and who does not have one
Ketamine treatment is a newer therapeutic tool, and who it suits is settled by assessment rather than by reading a list. The assessment has two parts, and a service that runs only one of them, or neither, is not screening you. Most of what comes up in it is worked with rather than ruled out.
The physical assessment checks how your body will handle the short rise in blood pressure and heart rate that follows a dose. For most people that passes without incident. A small number of conditions make it unsafe: an aneurysm or arteriovenous malformation, a history of bleeding in the brain, a recent heart attack or stroke, a known allergy to ketamine, or anything else where a brief rise in blood pressure carries serious risk.
The psychiatric assessment looks at whether the experience itself is safe for you right now. Ketamine produces altered perception and dissociation by design, and a small number of states make that unsafe: active psychosis, a diagnosis of schizophrenia, or a manic episode of bipolar disorder. Timing matters here more than in the physical assessment, and an answer of not now is different from an answer of never.
A current, untreated substance use disorder, particularly one involving ketamine or other dissociatives, is addressed first rather than alongside, because ketamine carries recognised potential for misuse.
Absolute exclusions (common across clinical protocols)
- Current or past psychotic disorder: schizophrenia, schizoaffective disorder, delusional disorder, or psychotic features during a mood episode.
- Current mania or hypomania, or bipolar I with a recent manic episode.
- Active substance use disorder, especially involving ketamine, PCP or other dissociatives, stimulants, or moderate-to-severe alcohol use.
- Acute suicidal risk (a current plan or intent) that needs inpatient care rather than an outpatient or retreat setting.
- Delirium, dementia or significant cognitive impairment.
- Inability to give informed consent.
Relative exclusions (need a psychiatrist’s judgement case by case)
- A first-degree relative with a psychotic disorder. Many trials treat this as an absolute exclusion.
- Bipolar II, or bipolar I that is stable on a mood stabiliser.
- Borderline personality disorder with recent self-harm or marked instability.
- Dissociative disorders (DID or severe depersonalisation), and PTSD with prominent dissociation.
- Severe eating disorder, especially anorexia that isn’t medically stable.
- A history of ketamine misuse, even if it is now in remission.
- A history of severe adverse reactions to psychedelics or dissociatives.
A real assessment covers medical and psychiatric history, current medication, substance use, heart health, and a clear account of previous treatment. It is a conversation with a clinician, not a form to score yourself against: the same fact means different things depending on everything else in the picture.
Checked for medical accuracy by Dr Christopher Gauci, MD MRCS(Ed) EDAIC on 1 October 2026. The check covers this section. Everything else on the page is written by our editorial team and verified against primary sources.
At Hive Bio, a course is planned for before a pregnancy or after breastfeeding ends. The psychiatrist goes through your history, including any past use of alcohol or drugs, and if you already have a psychiatrist, their assessment can be used. Whether infusions are right for you is confirmed there, before any dates are set. If your PTSD comes with spells of feeling unreal or cut off, describe them as plainly as you can, with how often they happen. To begin, tell us in a short form what you have tried for PTSD.
Where it is done in the US, the UK and the EU, and our course of infusions in Malta
In the United States, ketamine infusions for PTSD are given off-label at outpatient clinics, and most people choose among clinics they can reach from home. In the United Kingdom, infusions are legal but hard to get: the ketamine service at Oxford Health NHS Foundation Trust, which people pay for themselves, takes new patients only from Oxfordshire and Buckinghamshire (its FAQ). In the EU, it depends on the country and the doctor, and who can prescribe ketamine in each country is set out separately.
Hive Bio offers a fixed course in Malta that people travel to from anywhere, with no regional rules. There is no GP letter to wait for, because our psychiatrist sees you directly. The doctor who gives the infusion stays with you for all of it, and the course ends at six sessions rather than running on.
Coming from abroad for treatment changes the order of things. Finding out at the third infusion that the course does not suit you would cost you the travel and the time off, so suitability is settled first, and the price is quoted in writing on a short call. We help plan the dates and your stay around them; flights and accommodation you book yourself.
For PTSD, the useful question is what happens around the six infusions. Here that means a psychiatrist who looks at your trauma history before anything is booked, a doctor at every infusion, and sessions with a psychotherapist after the course, with room for your own therapist to stay involved. The course of infusions on our home page lists what is included, and you can apply with a short form and a call.
Considering infusions for PTSD?
A psychiatrist reads your history and confirms whether a course of six infusions suits you before any dates are set. A short call explains how the course runs and what it costs.
No payment and no booking at this step.
Common questions
Does ketamine help PTSD?
For some people, in small trials. Two controlled trials in civilians found PTSD symptoms falling more on ketamine than on the comparison drug, and the largest trial, in veterans, found no difference from placebo (Feder and colleagues, 2014 and 2021; Abdallah and colleagues, 2022). The figures are in the research section above. If you are weighing it up, a first call with our team goes through how the course runs and what the psychiatrist will want to know.
Is ketamine FDA approved for PTSD?
No. In the United States ketamine is approved as an anaesthetic, which is what its FDA label covers. Doctors who give it for PTSD prescribe it off-label, on their own clinical judgement. Our course in Malta works the same way, and the doctors who give it are named with their registrations.
How many ketamine infusions for PTSD?
The trials used one infusion, six over two weeks, or eight over four weeks, and a 2026 review found several infusions did better than one (Yin and colleagues). Our course is six over three weeks, two a week. What the course includes is on our home page.
Low dose ketamine for PTSD?
The veterans’ trial compared a low dose, 0.2 mg per kilogram of body weight, with the standard 0.5 mg per kilogram, and neither changed PTSD more than placebo (Abdallah and colleagues, 2022). The 2026 review reads early signs that repeated low doses may hold an effect longer, and calls the evidence preliminary (Yin and colleagues). On our course the dose is prescribed by the doctor who gives the infusions, and you can ask him about it before the first one; the doctors are listed with their registrations.
Ketamine treatment for PTSD near me?
In the US, outpatient clinics are the usual route. In the UK, services are few and some take patients only from their own area. Our course in Malta is open to people from any country, and you do not need a GP letter. If you are in the UK and weighing travel, what is available there and how to reach it is set out separately.
What you can plan around a PTSD course is what comes before the infusions and what follows them. Decide which symptoms you most want help with and write them down. Put therapy for the trauma in place for the weeks after the last infusion, whether with your own therapist or with ours. Keep notes between infusions and bring them to each one. On the Hive Bio course in Malta, a psychiatrist looks at your trauma history and confirms that infusions suit you before any dates are set, and a doctor gives every infusion.